A history of arterial hypertension does not affect mortality in patients hospitalised with congestive heart failure.

Heart
Finn GustafssonDIAMOND study group

Abstract

To evaluate the importance of a history of hypertension on long-term mortality in a large cohort of patients hospitalised with congestive heart failure (CHF). Retrospective analysis of 5491 consecutive patients, of whom 24% had a history of hypertension. 60% of the patients had non-systolic CHF, and 57% had ischaemic heart disease. 38 primary, secondary and tertiary hospitals in Denmark. Total mortality 5-8 years after inclusion in the registry. Female sex and preserved left ventricular systolic function was more common among patients with a history of hypertension. 72% of the patients died during follow up. A hypertension history did not affect mortality risk (hazard ratio (HR) 0.99, 95% confidence interval (CI) 0.92 to 1.07). Correction for differences between the normotensive and hypertensive groups at baseline in a multivariate model did not alter this result (HR 1.08, 95% CI 1.00 to 1.17, p = 0.06). The hazard ratio was similar in patients with and without a history of ischaemic heart disease. Hence, a specific effect of hypertension in the group of patients with CHF with ischaemic heart disease, as suggested in earlier studies, could not be confirmed. A history of arterial hypertension did not affect mortality in patients...Continue Reading

References

Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Oct 1, 1993·Journal of the American College of Cardiology·K K HoD Levy
May 22, 1996·JAMA : the Journal of the American Medical Association·D LevyK K Ho
Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Oct 8, 1997·Journal of the American College of Cardiology·B A BartC M O'Connor
Aug 26, 1998·European Heart Journal·P J CowburnM Komajda
Jan 19, 1999·Archives of Internal Medicine·M SenniM M Redfield
Feb 13, 2001·European Heart Journal·K F FoxG C Sutton
Jul 24, 2001·European Heart Journal·A MosterdD E Grobbee
Jan 22, 2003·Journal of the American College of Cardiology·Frederick A MasoudiHarlan M Krumholz
Jan 22, 2005·Journal of Human Hypertension·E KazzamM G Nicholls

❮ Previous
Next ❯

Citations

Apr 27, 2012·BMC Cardiovascular Disorders·Charlotte AnderssonUNKNOWN EchoCardiography and Heart Outcome Study (ECHOS) investigators
Jun 6, 2020·Platelets·Håkon S JohnsenJohn-Bjarne Hansen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.